VIRIDIAN THERAPEUTICS INC

Ticker: VRDN CUSIP: 92790C104 Class: Common Stock

OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM's Holding History (CIK: 0001132716)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 131,294 Value ($000) $1,835 Avg Close $13.57 Range $9.90 - $16.29
Q1 2025
Shares 107,088 Value ($000) $1,444 Avg Close $17.03 Range $13.23 - $21.58
Q4 2024
Shares 44,600 Value ($000) $855 Avg Close $21.74 Range $17.06 - $27.20
Q2 2024
Shares 10,057 Value ($000) $131 Avg Close $13.84 Range $11.40 - $17.69
Q1 2024
Shares 16,457 Value ($000) $288 Avg Close $19.39 Range $16.16 - $24.18
Q4 2023
Shares 30,000 Value ($000) $653 Avg Close $15.79 Range $10.93 - $23.53
Q3 2023
Shares 84,836 Value ($000) $1,301 Avg Close $19.08 Range $14.64 - $25.05
Q2 2023
Shares 74,836 Value ($000) $1,780 Avg Close $25.65 Range $21.96 - $30.30
Q1 2023
Shares 63,543 Value ($000) $1,617 Avg Close $32.06 Range $24.76 - $39.00
Q3 2022
Shares 81,870 Value ($000) $1,679,000 Avg Close $17.98 Range $10.47 - $26.22
Q2 2022
Shares 34,389 Value ($000) $398,000 Avg Close $13.44 Range $9.47 - $20.18